Aurora Cannabis' Latest Debacle Couldn't Come at a Worse Time
For Aurora Cannabis (NYSE: ACB), there has been a series of few steps forward and multiple steps back over the past few months. And now you can add another backward move for the Canadian cannabis producer.
Germany has suspended sales of Aurora's medical cannabis products in the country, according to a report by Marijuana Business Daily. The company reported abysmal fiscal 2020 first-quarter results in November. However, one of the few bright spots in those results was higher international medical cannabis revenue, most of which was generated in Germany. The dimming of that bright spot arguably couldn't come at a worse time for Aurora.
A rustic German flag framed by a pile of cannabis leaves. Image source: Getty Images.
Source Fool.com
